These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20178161)

  • 1. [Role of dopamine receptor agonists in the treatment of depression in patients with Parkinson's disease].
    Fedorova NV; Miretskaia AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12):87-92. PubMed ID: 20178161
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine agonists in the treatment of non-motor symptoms of Parkinson's disease: depression.
    Lemke MR
    Eur J Neurol; 2008 Sep; 15 Suppl 2():9-14. PubMed ID: 18702737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine agonists in Parkinson's disease.
    Yamamoto M; Schapira AH
    Expert Rev Neurother; 2008 Apr; 8(4):671-7. PubMed ID: 18416667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New dopamine agonist pramipexole improves parkinsonism and depression in Parkinson's disease.
    Harada T; Ishizaki F; Horie N; Nitta Y; Yamada T; Sasaki T; Nagakane T; Yasumatsu Y; Nitta K; Katsuoka H
    Hiroshima J Med Sci; 2011 Dec; 60(4):79-82. PubMed ID: 22389951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine agonists on neuropsychiatric symptoms of Parkinson's disease.
    Rektorová I
    Neurodegener Dis; 2010; 7(1-3):206-9. PubMed ID: 20224287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of antidepressant medication in Parkinson's disease patients is not affected by the type of antiparkinson medication.
    Krøigård T; Christensen J; Wermuth L; Ritz B; Lassen CF
    J Parkinsons Dis; 2014; 4(3):327-30. PubMed ID: 24919822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor agonists and depression in Parkinson's disease.
    Picillo M; Rocco M; Barone P
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S81-4. PubMed ID: 20123564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor agonists and sleep disturbances in Parkinson's disease.
    Chaudhuri KR; Logishetty K
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S101-4. PubMed ID: 20123546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of acute psychotic anxious depression in a patient with Parkinson's disease after treatment with quetiapine.
    Link S; Paulus W; Bandelow B
    Mov Disord; 2009 Dec; 24(16):2431-2. PubMed ID: 19890998
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease.
    Lemke MR; Brecht HM; Koester J; Reichmann H
    J Neurol Sci; 2006 Oct; 248(1-2):266-70. PubMed ID: 16814808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor agonists in the treatment of advanced Parkinson's disease.
    Stocchi F
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S54-7. PubMed ID: 20123558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine agonists for Parkinson's disease.
    Sharma J; MacMahon D; Stewart D
    Lancet; 2003 Jan; 361(9351):84; author reply 84. PubMed ID: 12517504
    [No Abstract]   [Full Text] [Related]  

  • 13. Unraveling depression in Parkinson's disease.
    Antonini A
    Eur J Neurol; 2008 Sep; 15(9):885-6. PubMed ID: 18796071
    [No Abstract]   [Full Text] [Related]  

  • 14. [Idiopathic Parkinson's disease: practical hints for the treatment].
    Ludin HP
    Praxis (Bern 1994); 2005 Jul; 94(30-31):1147-50. PubMed ID: 16117469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current treatment strategies for Parkinson's disease].
    Südmeyer M; Wojtecki L; Schnitzler A
    Fortschr Neurol Psychiatr; 2011 Dec; 79(12):733-43. PubMed ID: 22161168
    [No Abstract]   [Full Text] [Related]  

  • 16. GSK's Requip slow the loss of dopamine function in Parkinson's disease.
    Aviat Space Environ Med; 2002 Jul; 73(7):733. PubMed ID: 12137117
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.
    Leentjens AF
    Drugs; 2011 Feb; 71(3):273-86. PubMed ID: 21319866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Parkinson's disease.
    Hely MA; Fung VS; Morris JG
    J Clin Neurosci; 2000 Nov; 7(6):484-94. PubMed ID: 11029227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease: recent advances.
    Pandey S
    J Assoc Physicians India; 2012 Jun; 60():30-2. PubMed ID: 23409418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor agonists in the therapy of Parkinson's disease.
    Foley P; Gerlach M; Double KL; Riederer P
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1375-446. PubMed ID: 15480844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.